IBDEI34Z ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50093,1,3,0)
 ;;=3^Perioral Dermatitis
 ;;^UTILITY(U,$J,358.3,50093,1,4,0)
 ;;=4^L71.0
 ;;^UTILITY(U,$J,358.3,50093,2)
 ;;=^5009274
 ;;^UTILITY(U,$J,358.3,50094,0)
 ;;=L71.1^^193^2487^299
 ;;^UTILITY(U,$J,358.3,50094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50094,1,3,0)
 ;;=3^Rhinophyma
 ;;^UTILITY(U,$J,358.3,50094,1,4,0)
 ;;=4^L71.1
 ;;^UTILITY(U,$J,358.3,50094,2)
 ;;=^106083
 ;;^UTILITY(U,$J,358.3,50095,0)
 ;;=L71.8^^193^2487^300
 ;;^UTILITY(U,$J,358.3,50095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50095,1,3,0)
 ;;=3^Rosacea NEC
 ;;^UTILITY(U,$J,358.3,50095,1,4,0)
 ;;=4^L71.8
 ;;^UTILITY(U,$J,358.3,50095,2)
 ;;=^5009275
 ;;^UTILITY(U,$J,358.3,50096,0)
 ;;=L71.9^^193^2487^301
 ;;^UTILITY(U,$J,358.3,50096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50096,1,3,0)
 ;;=3^Rosacea,Unspec
 ;;^UTILITY(U,$J,358.3,50096,1,4,0)
 ;;=4^L71.9
 ;;^UTILITY(U,$J,358.3,50096,2)
 ;;=^5009276
 ;;^UTILITY(U,$J,358.3,50097,0)
 ;;=L72.0^^193^2487^145
 ;;^UTILITY(U,$J,358.3,50097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50097,1,3,0)
 ;;=3^Epidermal Cyst
 ;;^UTILITY(U,$J,358.3,50097,1,4,0)
 ;;=4^L72.0
 ;;^UTILITY(U,$J,358.3,50097,2)
 ;;=^5009277
 ;;^UTILITY(U,$J,358.3,50098,0)
 ;;=L72.12^^193^2487^325
 ;;^UTILITY(U,$J,358.3,50098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50098,1,3,0)
 ;;=3^Trichodermal Cyst
 ;;^UTILITY(U,$J,358.3,50098,1,4,0)
 ;;=4^L72.12
 ;;^UTILITY(U,$J,358.3,50098,2)
 ;;=^5009279
 ;;^UTILITY(U,$J,358.3,50099,0)
 ;;=L72.2^^193^2487^310
 ;;^UTILITY(U,$J,358.3,50099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50099,1,3,0)
 ;;=3^Steatocystoma Multiplex
 ;;^UTILITY(U,$J,358.3,50099,1,4,0)
 ;;=4^L72.2
 ;;^UTILITY(U,$J,358.3,50099,2)
 ;;=^5009280
 ;;^UTILITY(U,$J,358.3,50100,0)
 ;;=L72.8^^193^2487^154
 ;;^UTILITY(U,$J,358.3,50100,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50100,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue NEC
 ;;^UTILITY(U,$J,358.3,50100,1,4,0)
 ;;=4^L72.8
 ;;^UTILITY(U,$J,358.3,50100,2)
 ;;=^5009282
 ;;^UTILITY(U,$J,358.3,50101,0)
 ;;=L72.9^^193^2487^155
 ;;^UTILITY(U,$J,358.3,50101,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50101,1,3,0)
 ;;=3^Follicular Cysts of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,50101,1,4,0)
 ;;=4^L72.9
 ;;^UTILITY(U,$J,358.3,50101,2)
 ;;=^5009283
 ;;^UTILITY(U,$J,358.3,50102,0)
 ;;=L73.0^^193^2487^4
 ;;^UTILITY(U,$J,358.3,50102,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50102,1,3,0)
 ;;=3^Acne Keloid
 ;;^UTILITY(U,$J,358.3,50102,1,4,0)
 ;;=4^L73.0
 ;;^UTILITY(U,$J,358.3,50102,2)
 ;;=^2149
 ;;^UTILITY(U,$J,358.3,50103,0)
 ;;=L73.2^^193^2487^162
 ;;^UTILITY(U,$J,358.3,50103,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50103,1,3,0)
 ;;=3^Hidradenitis Suppurativa
 ;;^UTILITY(U,$J,358.3,50103,1,4,0)
 ;;=4^L73.2
 ;;^UTILITY(U,$J,358.3,50103,2)
 ;;=^278979
 ;;^UTILITY(U,$J,358.3,50104,0)
 ;;=L73.9^^193^2487^156
 ;;^UTILITY(U,$J,358.3,50104,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50104,1,3,0)
 ;;=3^Follicular Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,50104,1,4,0)
 ;;=4^L73.9
 ;;^UTILITY(U,$J,358.3,50104,2)
 ;;=^5009286
 ;;^UTILITY(U,$J,358.3,50105,0)
 ;;=L82.0^^193^2487^163
 ;;^UTILITY(U,$J,358.3,50105,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50105,1,3,0)
 ;;=3^Inflamed Seborrheic Keratosis
 ;;^UTILITY(U,$J,358.3,50105,1,4,0)
 ;;=4^L82.0
